These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Role of high-resolution magnetic resonance imaging for differentiating melanin-containing skin tumors. Mäurer J; Knollmann FD; Schlums D; Garbe C; Vogl TJ; Bier J; Felix R Invest Radiol; 1995 Nov; 30(11):638-43. PubMed ID: 8557504 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197 [TBL] [Abstract][Full Text] [Related]
28. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma]. Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997 [TBL] [Abstract][Full Text] [Related]
29. Contribution of MRI and color Doppler sonography in breast cancer diagnosis. Rigauts H; Casselman J; Steyaert L; Devlies F; Pattyn G J Belge Radiol; 1993 Aug; 76(4):226-31. PubMed ID: 8294376 [TBL] [Abstract][Full Text] [Related]
30. Limitations of the keyhole technique for quantitative dynamic contrast-enhanced breast MRI. Bishop JE; Santyr GE; Kelcz F; Plewes DB J Magn Reson Imaging; 1997; 7(4):716-23. PubMed ID: 9243393 [TBL] [Abstract][Full Text] [Related]
32. Unusual enhancement on gadolinium-enhanced MRI in a case of primary cerebellar lymphoma. Gupta RK; Gupta S; Mittal P; Pandey R; Kohli A; Gujral RB Neuroradiology; 1993; 35(6):454-6. PubMed ID: 8377920 [No Abstract] [Full Text] [Related]
33. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Heiberg EV; Perman WH; Herrmann VM; Janney CG Magn Reson Imaging; 1996; 14(4):337-48. PubMed ID: 8782170 [TBL] [Abstract][Full Text] [Related]
34. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Flickinger FW; Allison JD; Sherry RM; Wright JC Magn Reson Imaging; 1993; 11(5):617-20. PubMed ID: 8345775 [TBL] [Abstract][Full Text] [Related]
35. Computed model of gadolinium enhanced MRI of breast disease. Kenney PJ; Sobol WT; Smith JK; Morgan DE Eur J Radiol; 1997 Feb; 24(2):109-19. PubMed ID: 9097052 [TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging of choroidal melanoma with and without gadolinium contrast enhancement. Bond JB; Haik BG; Mihara F; Gupta KL Ophthalmology; 1991 Apr; 98(4):459-66. PubMed ID: 2052299 [TBL] [Abstract][Full Text] [Related]
37. The indeterminate breast mass: assessment using contrast enhanced magnetic resonance imaging. Hickman PF; Moore NR; Shepstone BJ Br J Radiol; 1994 Jan; 67(793):14-20. PubMed ID: 8298869 [TBL] [Abstract][Full Text] [Related]
38. [Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast]. Heywang SH; Hilbertz T; Pruss E; Wolf A; Permanetter W; Eiermann W; Lissner J Digitale Bilddiagn; 1988 Mar; 8(1):7-13. PubMed ID: 3383539 [TBL] [Abstract][Full Text] [Related]
39. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Stomper PC; Herman S; Klippenstein DL; Winston JS; Edge SB; Arredondo MA; Mazurchuk RV; Blumenson LE Radiology; 1995 Nov; 197(2):387-95. PubMed ID: 7480682 [TBL] [Abstract][Full Text] [Related]
40. Improved visualization of breast lesions with gadolinium-enhanced magnetization transfer MR imaging. Schreiber WG; Brix G; Knopp MV; Hess T; Lorenz WJ Magn Reson Med; 1996 Jun; 35(6):861-9. PubMed ID: 8744014 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]